Characterization of right ventricular function after monocrotaline-induced pulmonary hypertension in the intact rat
- 1 November 2006
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 291 (5) , H2424-H2430
- https://doi.org/10.1152/ajpheart.00369.2006
Abstract
We characterized hemodynamics and systolic and diastolic right ventricular (RV) function in relation to structural changes in the rat model of monocrotaline (MCT)-induced pulmonary hypertension. Rats were treated with MCT at 30 mg/kg body wt (MCT30, n = 15) and 80 mg/kg body wt (MCT80, n = 16) to induce compensated RV hypertrophy and RV failure, respectively. Saline-treated rats served as control (Cont, n = 13). After 4 wk, a pressure-conductance catheter was introduced into the RV to assess pressure-volume relations. Subsequently, rats were killed, hearts and lungs were rapidly dissected, and RV, left ventricle (LV), and interventricular septum (IVS) were weighed and analyzed histochemically. RV-to-(LV + IVS) weight ratio was 0.29 ± 0.05 in Cont, 0.35 ± 0.05 in MCT30, and 0.49 ± 0.10 in MCT80 ( P < 0.001 vs. Cont and MCT30) rats, confirming MCT-induced RV hypertrophy. RV ejection fraction was 49 ± 6% in Cont, 40 ± 12% in MCT30 ( P < 0.05 vs. Cont), and 26 ± 6% in MCT80 ( P < 0.05 vs. Cont and MCT30) rats. In MCT30 rats, cardiac output was maintained, but RV volumes and filling pressures were significantly increased compared with Cont (all P < 0.05), indicating RV remodeling. In MCT80 rats, RV systolic pressure, volumes, and peak wall stress were further increased, and cardiac output was significantly decreased (all P < 0.05). However, RV end-systolic and end-diastolic stiffness were unchanged, consistent with the absence of interstitial fibrosis. MCT-induced pressure overload was associated with a dose-dependent development of RV hypertrophy. The most pronounced response to MCT was an overload-dependent increase of RV end-systolic and end-diastolic volumes, even under nonfailing conditions.Keywords
This publication has 50 references indexed in Scilit:
- Microarray analysis reveals pivotal divergent mRNA expression profiles early in the development of either compensated ventricular hypertrophy or heart failurePhysiological Genomics, 2005
- Contractile reserve but not tension is reduced in monocrotaline-induced right ventricular hypertrophyAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Mechanical Load-Dependent Regulation of Gene Expression in Monocrotaline-Induced Right Ventricular Hypertrophy in the RatCirculation Research, 2003
- Cardiac β-Adrenoceptor Changes in Monocrotaline-Treated Rats: Differences Between Membrane Preparations From Whole Ventricles and Isolated Ventricular CardiomyocytesJournal of Cardiovascular Pharmacology, 2003
- Progressive Development of Pulmonary Hypertension Leading to Right Ventricular Hypertrophy Assessed by Echocardiography in Rats.Experimental Animals, 2003
- Induction of Thyroid Hormone-Degrading Deiodinase in Cardiac Hypertrophy and FailureEndocrinology, 2002
- Structural remodeling and mechanical dysfunction of cardiac myocytes in heart failureJournal of Molecular and Cellular Cardiology, 1995
- Continuous measurement of left ventricular volume in animals and humans by conductance catheter.Circulation, 1984
- The end-systolic pressure-volume relation of the ventricle: definition, modifications and clinical use.Circulation, 1981
- Performance of the failing and nonfailing right ventricle of patients with pulmonary hypertensionThe American Journal of Cardiology, 1979